← Open Payments lookup

LAUREN LEPCHITZ: Open Payments

NPI 1023517182 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,043 in 107 payments from 20 companies in 2025. Trend: 2023 $3,224 · 2024 $4,615 · 2025 $4,043

Food & beverage: $2,488Travel & lodging: $1,556
CompanyPaymentsAmount
Insulet Corporation7$1,837
Sequel Med Tech, LLC15$383
Novo Nordisk Inc21$254
Novartis Pharmaceuticals Corporation11$239
Tandem Diabetes Care, Inc.2$173
SANOFI-AVENTIS U.S. LLC6$159
Mannkind Corporation7$150
Lilly USA, LLC8$146
Dexcom, Inc.6$110
Abbott Laboratories6$103

Products named: Omnipod, TWIIST, LEQVIO, t:slim X2 Insulin Pump with Control-IQ, TZIELD, AFREZZA, Ozempic, Dexcom G6 Transmitter.

Industry payments across GA — which companies pay providers there.